RHY 25.4% 9.7¢ rhythm biosciences limited

Ann: Final Antibody Selection Complete, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 93 Posts.
    lightbulb Created with Sketch. 29
    “tighter than a Tasmanian family reunion” hahah you’re a funny guy!
    Ahem yeah I meant Q1 2019 but HC wouldn’t let my go back and change it. Yep I read the extensive Sprout8 report when it was first released.
    IMO the biggest risks are competition (liquid biopsy is making big claims) and the risk that trials 6 & 7 don’t deliver. If we remain on schedule Colostat will hit market years before an equivalent liquid biopsy test is available. Based on all the previous work clinical trials should be successful and that’ll determine the value of this company. Let’s hope they hit a six in trial 6! I’d like to know their anticipated timeframe...
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
9.7¢
Change
-0.033(25.4%)
Mkt cap ! $15.41M
Open High Low Value Volume
12.0¢ 12.0¢ 9.7¢ $114.8K 1.082M

Buyers (Bids)

No. Vol. Price($)
1 5500 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
10.0¢ 164688 2
View Market Depth
Last trade - 16.10pm 25/11/2024 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.